Skip to content
healthcare.dev

Mesalamine

NDC 67877-717, Mesalamine, capsule, extended release, from Ascend Laboratories, LLC.

Product NDC
67877-717
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214242
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE.375 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
67877-717-0567877071705500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67877-717-05)
67877-717-1267877071712120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67877-717-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43f69db3-81ac-4da4-a61f-fbba6299d9c2
  • NADAC price for package 67877071712

    GET /v1/drugs/nadac/67877071712

Use it

Look up 67877-717 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.